Sunday, October 20, 2013

Ameridose insurer says it's not liable in meningitis outbreak

Lloyd’s of London, the international insurance firm, is asking a federal judge to declare that a $5 million insurance policy cannot be tapped to pay claims from victims of the fatal fungal meningitis outbreak that sickened 750 patients and took the lives of 64 people, including 16 who were treated in Tennessee.
In a suit filed in U.S. District Court in Boston, lawyers for the insurance firm said the policy was taken out by Ameridose LLC, which has common ownership with the New England Compounding Center, the bankrupt Massachusetts firm blamed for the outbreak.
“NECC is not an insured” under the Lloyd’s policy, the complaint states.
continue to read here

1 comment:

Kenneth Woliner, MD said...

I predict physicians who injected the tainted drugs will be the ones that ultimately pay the claims. Causes of action include:

- violating state laws and rules regarding "office use" compounded drugs

- failure to have Pedigree information on the drugs they injected

- failure to do "due diligence" when obtaining compounded drugs (as opposed to manufactured drugs which were FDA approved) because they purchased compounded drugs for "price reasons alone"

Doctors will settle out of court for their policy limits.

Kenneth Woliner, MD
www.holisticfamilymed.com